Page last updated: 2024-09-03

mozavaptan and Chronic Disease

mozavaptan has been researched along with Chronic Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, JK; Martin, PY; Meng, X; Morris, K; Ohara, M; Pattison, T; Schrier, RW; St John, J; Xu, DL1
Lankhuizen, IM; Saxena, PR; Schoemaker, RG; van Veghel, R1

Other Studies

2 other study(ies) available for mozavaptan and Chronic Disease

ArticleYear
Upregulation of aquaporin-2 water channel expression in chronic heart failure rat.
    The Journal of clinical investigation, 1997, Apr-01, Volume: 99, Issue:7

    Topics: Animals; Aquaporin 4; Aquaporins; Benzazepines; Chronic Disease; Gene Expression Regulation; Heart Failure; Immunohistochemistry; Ion Channels; Male; Rats; Rats, Sprague-Dawley; Sodium; Up-Regulation; Water-Electrolyte Balance

1997
Vascular and renal effects of vasopressin and its antagonists in conscious rats with chronic myocardial infarction; evidence for receptor shift.
    European journal of pharmacology, 2001, Jul-06, Volume: 423, Issue:2-3

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Chronic Disease; Consciousness; Coronary Vessels; Dose-Response Relationship, Drug; Indoles; Kidney; Ligation; Male; Myocardial Infarction; Pyrrolidines; Rats; Rats, Wistar; Receptors, Vasopressin; Urination; Urodynamics; Vasopressins

2001